MedPath

The Christie NHS Foundation Trust

๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom
Ownership
-
Established
2007-01-01
Employees
-
Market Cap
-
Website
http://www.christie.nhs.uk/

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Phase 2
Terminated
Conditions
Metastatic Melanoma
Interventions
Genetic: Tumour Infiltrating Lymphocytes
First Posted Date
2013-11-26
Last Posted Date
2023-04-20
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
2
Registration Number
NCT01995344
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study

Not Applicable
Completed
Conditions
Sarcoma
First Posted Date
2013-10-08
Last Posted Date
2017-04-26
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
15
Registration Number
NCT01956019
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

The Christie NHS Foundation Trust, Manchester, United Kingdom

NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)

Phase 3
Completed
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
Radiation: Radiotherapy
First Posted Date
2013-09-25
Last Posted Date
2021-10-19
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
338
Registration Number
NCT01950689
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Cheltenham General Hospital, Cheltenham, Gloucestershire, United Kingdom

๐Ÿ‡ฌ๐Ÿ‡ง

Clatterbridge Centre for Oncology, Bebington, Merseyside, United Kingdom

๐Ÿ‡ฌ๐Ÿ‡ง

St James' Hospital, Leeds, West Yorkshire, United Kingdom

and more 18 locations

Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers

Phase 3
Completed
Conditions
Ampullary Cancer
Cholangiocarcinoma
Biliary Tract Cancer
Gallbladder Cancer
Interventions
Other: Active Symptom Control
Drug: 5 FU
First Posted Date
2013-08-20
Last Posted Date
2020-01-28
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
162
Registration Number
NCT01926236
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Queen Elizabeth Hospital, Birmingham, United Kingdom

๐Ÿ‡ฌ๐Ÿ‡ง

Bristol Haematology & Oncology Centre, Bristol, United Kingdom

๐Ÿ‡ฌ๐Ÿ‡ง

North Cumbria University Hospitals, Carlisle, United Kingdom

and more 14 locations

Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

Suspended
Conditions
Sarcoma
Lymphoma
First Posted Date
2013-08-14
Last Posted Date
2015-02-04
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
50
Registration Number
NCT01921998
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

The Christie NHS Foundation Trust, Manchester, United Kingdom

The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study

Not Applicable
Conditions
Prostate Cancer
First Posted Date
2013-04-30
Last Posted Date
2014-07-30
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
10
Registration Number
NCT01842750
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy

Phase 1
Terminated
Conditions
CD19 Positive Non-Hodgkin Lymphoma
First Posted Date
2011-12-16
Last Posted Date
2023-04-19
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
17
Registration Number
NCT01493453
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

The Christie NHS Foundation Trust, Manchester, United Kingdom

Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma

Phase 2
Completed
Conditions
Follicular Lymphoma
Interventions
First Posted Date
2011-12-16
Last Posted Date
2019-10-15
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
76
Registration Number
NCT01493479
Locations
๐Ÿ‡ซ๐Ÿ‡ท

Centre Hospitalier Universitaire de Lille, Lille, France

๐Ÿ‡ซ๐Ÿ‡ท

Centre Hospitalier Universitaire de Nantes, Nantes, France

๐Ÿ‡ซ๐Ÿ‡ท

Centre Henri Becquerel, Rouen, France

and more 4 locations

Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus

Phase 1
Conditions
Carcinoma of the Oesophagus
Interventions
Radiation: Radical external beam radiotherapy, 50Gy in 25 fractions
First Posted Date
2011-10-27
Last Posted Date
2013-08-19
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
36
Registration Number
NCT01460888
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

The Christie NHS Foundation Trust, Manchester, United Kingdom

๐Ÿ‡ฌ๐Ÿ‡ง

Southampton General Hospital, Southampton, United Kingdom

Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy

Not Applicable
Completed
Conditions
Bladder Cancer
First Posted Date
2011-04-27
Last Posted Date
2021-08-13
Lead Sponsor
The Christie NHS Foundation Trust
Target Recruit Count
50
Registration Number
NCT01343121
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

The Christie NHS Foundation Trust, Manchester, Gtr Manchester, United Kingdom

ยฉ Copyright 2025. All Rights Reserved by MedPath